| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Ely Benaim last filed a Form 4 in January 2023, as Chief Medical Officer at NVCR. The filings on record cover 2 companies. From February 2018 to January 2023, the filings on record show 0 open-market purchases and 17 sales. Ely Benaim's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Ely Benaim's trades have earned a strong insider score of 73/100 across 14 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +38.0%.
At the last filing, the largest reported position was 28,770 shares of NVCR. The NVCR filings lean toward selling, a net 44,366 shares.
Shares as reported in the last Form 4 for each company; the most recent is from January 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 2,918 | $131.53 | $383,804.54 | -8.1% | |
| Mar 4, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 5,363 | $146.12 | $783,662.45 | -12.9% | |
| Dec 21, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 2,484 | $156.71 | $389,267.64 | -7.8% | |
| Aug 3, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 660 | $76.06 | $50,199.60 | -2.2% | |
| Jul 31, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 341 | $76.39 | $26,048.31 | -1.1% | |
| May 12, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 2,595 | $64.78 | $168,104.10 | -17.1% | |
| May 11, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 1,611 | $63.73 | $102,665.81 | -9.6% |